Drugs / IDN 5243
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02568826 | Apr 2016 → Mar 2018 | — | Indena S.p.A | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IDN 5243 | “IDN 5243 is a new muscle relaxant molecule.” NCT02568826 ↗ |
| Route | Intramuscular | “administered intramuscularly at 4mg b.i.d. for 5 days” NCT02568826 ↗ |